Michelle Robertson

Insider Reports History

Entity
Individual
Location
C/O Momenta Pharmaceuticals, Inc., 301 Binney Street, Cambridge, Massachusetts
Signature
/s/ Daniel Calkins, Attorney in Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michelle Robertson:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Editas Medicine, Inc. EVP, CHIEF FINANCIAL OFFICER Common Stock 106,610 $1.16 M $10.90 May 11, 2023 Direct
Verastem, Inc. Director Common Stock 8,333 $26.3 K $3.16 Jun 18, 2024 Direct
GERON CORP EVP, Chief Financial Officer Employee Stock Option (Right to Buy) 250,000 Jun 6, 2024 Direct
Verastem, Inc. Director Stock Option (right to buy) 12,500 Jun 18, 2024 Direct

Insider Reports Filed by Michelle Robertson

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VSTM Verastem, Inc. Jun 18, 2024 2 0 4 Jun 20, 2024 Director
GERN GERON CORP Jun 6, 2024 1 0 4 Jun 7, 2024 EVP, Chief Financial Officer
VSTM Verastem, Inc. Mar 11, 2024 2 0 4 Mar 13, 2024 Director
GERN GERON CORP Feb 14, 2024 1 0 4 Feb 16, 2024 EVP, CHIEF FINANCIAL OFFICER
GERN GERON CORP Sep 25, 2023 1 0 4 Sep 27, 2023 EVP, Chief Financial Officer
GERN GERON CORP Sep 25, 2023 0 0 3 Sep 27, 2023 EVP, Chief Financial Officer
VSTM Verastem, Inc. May 15, 2023 1 0 4 May 16, 2023 Director
EDIT Editas Medicine, Inc. May 11, 2023 1 -9,369 4 May 15, 2023 EVP, CHIEF FINANCIAL OFFICER
EDIT Editas Medicine, Inc. Mar 2, 2023 3 -1,636 4 Mar 6, 2023 EVP, CHIEF FINANCIAL OFFICER
EDIT Editas Medicine, Inc. Feb 13, 2023 1 -41,435 4 Feb 15, 2023 EVP, CHIEF FINANCIAL OFFICER
EDIT Editas Medicine, Inc. Jan 10, 2023 1 -14,296 4 Jan 12, 2023 EVP, CHIEF FINANCIAL OFFICER
EDIT Editas Medicine, Inc. Dec 5, 2022 1 -1,974 4 Dec 6, 2022 EVP, CHIEF FINANCIAL OFFICER
EDIT Editas Medicine, Inc. Sep 6, 2022 1 -2,882 4 Sep 8, 2022 EVP, CHIEF FINANCIAL OFFICER
VSTM Verastem, Inc. Jun 22, 2022 1 0 4 Jun 24, 2022 Director
EDIT Editas Medicine, Inc. Jun 3, 2022 1 -17,617 4 Jun 6, 2022 EVP, CHIEF FINANCIAL OFFICER
VSTM Verastem, Inc. May 12, 2022 1 0 4/A Dec 20, 2022 Director
EDIT Editas Medicine, Inc. Mar 3, 2022 1 -13,290 4 Mar 7, 2022 EVP, CHIEF FINANCIAL OFFICER
EDIT Editas Medicine, Inc. Feb 10, 2022 2 0 4 Feb 11, 2022 CHIEF FINANCIAL OFFICER
EDIT Editas Medicine, Inc. Jan 11, 2022 1 -44,821 4 Jan 13, 2022 Chief Financial Officer
EDIT Editas Medicine, Inc. Dec 22, 2021 1 0 4 Dec 23, 2021 Chief Financial Officer
VSTM Verastem, Inc. Nov 15, 2021 1 0 4 Nov 17, 2021 Director
VSTM Verastem, Inc. Nov 15, 2021 0 0 3 Nov 17, 2021 Director
EDIT Editas Medicine, Inc. Aug 9, 2021 3 -73,375 4 Aug 10, 2021 Chief Financial Officer
EDIT Editas Medicine, Inc. Jun 28, 2021 3 -48,375 4 Jun 30, 2021 Chief Financial Officer